The global market for tissue engineering and regeneration technologies was valued at $4.8 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 12.8% to reach $9.8 billion by the end of 2030.

Tissue engineering and regeneration is a multidisciplinary field focused on producing biological substitutes to restore, maintain, or enhance tissue and organ function. Several emerging technologies are gaining ground as main areas for research and development: